Data+ Awards: BI helps Quintiles speed new drugs to market

Developing a new drug can cost millions of dollars and require years of research. The quicker a pharmaceutical company gets a product to market, the less time and money it spends on R&D and the faster it can begin to earn a return on its investment.

Technologies that can speed up a drug's trial period and more quickly analyze its odds of success can have a huge impact on the bottom line.

Quintiles knows that firsthand. The $4.8 billion company provides clinical research services to the pharmaceutical industry. Among other things, Quintiles plans and monitors clinical trials, recruits patients for trials and submits materials to regulatory agencies.

For the past four years the Cambridge, Mass.-based company has worked to create an integrated suite of software modules to handle all phases of drug research, development and trials.

Its software platform, Infosario, integrates the data and processes associated with a drug's life cycle and includes a data engine to collect, clean and prepare data for analysis. The data can be combined with clinical research data and information from other sources to provide predictive analysis.

Formally launched in 2010, Infosario uses elements from Oracle Business Intelligence Enterprise Edition, Siebel's CRM system, SAS Analytics, Microsoft SQL Server and Informatica's Master Data Management system, as well as Tibco's Spotfire data discovery and visualization tool. At its core is the Quintiles Data Factory, which contains the data operations and collection tools for extracting and organizing clinical and operational data from other repositories.

An executive at a Quintiles customer, a major pharmaceutical company, notes that the traditional method of planning a drug trial involves examining data from prior trials to develop the best approach. Infosario allows the company to design drug trials more quickly and effectively.

ROI

The Quintiles Infosario system allows researchers to revisit decisions made earlier within the same drug trial. That's a big benefit, says Quintiles CIO Richard Thomas, because "clinical trials take six, seven years, so feedback loops collect a lot of data along the way."

2014 ARN Women in ICT Awards - Nominate Now!: Nominations have opened for WIICTA 2014 and will stay open until October 22. But don't be late, be among the first in and NOMINATE NOW!!!

Tags applicationssoftwareQuintilesbusiness intelligence

More about InformaticaMicrosoftOracleSASTibco

ARN Directory | Distributors relevant to this article

ARN Directory | Vendors relevant to this article

Comments

Comments are now closed

 
Computerworld
CIO
Techworld
CMO

Latest News

01:38PM
Google Nexus 9 pre-sales start at $479
12:56PM
Xero: Larking about, Kiwi style...
11:39AM
World's most powerful life sciences supercomputing facility to stay in Victoria
11:18AM
Nextgen Networks appoints former AAPT exec as new MD
More News
21 Oct
NewLease & Red Hat Breakfast Briefing (Melbourne)
21 Oct
DCIM Solutions Architect
22 Oct
NewLease & Microsoft Technical Sessions
23 Oct
NewLease & Red Hat Breakfast Briefing (Sydney)
View all events